P. Chastagner et al., ASSOCIATION OF ANTICARDIOLIPIN ANTIBODIES AND AUTOIMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN, International journal of pediatric hematology/oncology, 3(4), 1996, pp. 267-271
Purpose: High levels of anticardiolipin antibodies (ACAs) have been de
monstrated in the serum of patients with autoimmune thrombocytopenic p
urpura (AITP). However, their clinical and pathogenic significance is
still unknown. To determine the role of ACAs in the occurrence and evo
lution of thrombocytopenia, we devised a prospective study in children
with acute and chronic AITP. Patients and Methods: ACA IgG levels wer
e assessed in each new patient admitted for AITP and in a control popu
lation. Antinuclear antibodies, lupus anticoagulant, and ACA levels we
re assessed monthly for at least 6 months in the case of positivity. T
he rate and interval of resolution of thrombocytemia were compared acc
ording to initial ACA levels and their evolution with time. Results: A
mong 39 thrombocytopenic children (32 with acute AITP and 7 with chron
ic AITP), 16 were ACA-positive (41%) while only 4 of 38 (10.5%) contro
l patients displayed ACAs. Evolution of thrombocytopenia was not diffe
rent in ACA-positive or negative patients, but the resolution of the t
hrombocytopenia was highly correlated with ACA disappearance. Platelet
count normalization usually occurred before ACA disappearance. Conclu
sion: This frequent association of ACA and AITP suggests that ACAs pla
y no role in the etiology of idiopathic thrombocytopenic purpura, but
rather it results from the increase of platelet destruction that occur
s during acute and chronic AITP.